3-Amino-2-Hydroxy Acetophenone.HCL

9005-55-3

Chenglian Pharmaceutical is an innovative high-tech pharmaceutical enterprise₹ that is market-oriented and realizes industrial development through R&D innovati★on and technology transformation.

key word:

Pharmaceutical innovative

Category:

Product Description

Integrity, innovation, cooperation, sharing, win-win

The company integrates multiple resources and strives to build£ a large health industry finance platform company i♥ntegrating pharmaceutical, intelligent medical, bio pharmaceutical R&D, indσustrial production and sales.

The chemical reactions involved in the existing products in↔clude Foucault reaction, nitration reaction, sulfonation re‍action, hydrogenation reaction, fluorination reaction, chlorina∑tion reaction, bromination reaction, diazotization reaction, format r&eaction, etc.

Related products

Sitagliptin Phosphate Monohydrate

Sitagliptin phosphate is a dipeptidyl peptidase-4 (DPP≠4) inhibitor developed by Merck. In October 2006, Sitagliptin phosphate Janu via was approved by FDA as the first DPP4 inhibitor for th¶e treatment of type ⅱ diabetes mellitus. The characteristics of tβhis drug are that it can stimulate insulin secretion while re​ducing hunger without causing weight gain. Hypoglycemia and ede&ma will not occur, and it is suitable for diabetic patients w©ith poor blood glucose control and frequent hypoglycemia.

Sumatriptan Succinate

Medication for migraine

Vildagliptin

Chenglian Pharmaceutical is an innovative high-techσ pharmaceutical enterprise that is market-oriented and realσizes industrial development through R&D innovation and technology transformation.

Ketoprofen

The non-steroidal anti-inflammatory drug ketoprofen is one of the most important prod≥ucts for the treatment of arthritis. It is well tolerated and has a low incidenc♠e of side effects

Pranlukast

Pranlukast, developed by Ono, is one of the three major leukotriene receptor εantagonists. In clinical application, it has good therapeutic effect on atopic asthma and otherε types of bronchial asthma, and the market prospect is huge. In the major category of asthma drugs,↑ leukotriene receptor antagonists have the fastest growing mar'ket share.

Avanafil

Chenglian Pharmaceutical is an innovative high-tech pharmaceutical enterprise that i✔s market-oriented and realizes industrial development through R&D innovation an₽d technology transformation.

Donepezil HCL

Treatment of mild to moderate Alzheimer's syndrome. It is the second drug approved by FDA for Alzh eimer's disease in the United States. Its treatment reaches the target dose and§ has low toxic and side effects. It has been widel♥y recognized by our medical community, and good tolerance is its biggest advantage. In Octo®ber 1999, Donepezil was launched in China under the trade name "Aricept", which i‍s the main chemical drug against Alzheimer's disease. At present, CFDA has approved a nu mber of domestic enterprises to produce donepezil preparations, the main d↑osage forms are tablets, capsules, dispersive tablets, oral disintegrating t£ablets.

Almotriptan

Migraine medication for adolescents

Apixaban

English name Apixaban Trade name ELIQUIS, tablet: Apixa×ban (Eliquis, Bristol-Myers Squibb/Pfizer), a direct o>ral factor Xa inhibitor, was approved for use in the 27 EU ‌member states. The world's first drug approved to prevent venous thromboembolism (VTE) in a¶dult patients undergoing elective hip or knee replacemen$t. From June 2019 to June 2020, the annual sales of apixaban $products overseas reached about $15.4 billion, with a year-on-year grow>th of nearly 32%, and the API consumption reached about 23,960 kg, with a year₽-on-year growth of about 28%. Compared with its main competitor, Riv♣aroxaban, the drug's annual overseas sales are about $4.5 billion higher∏.

Lenvatinib

Chenglian Pharmaceutical is an innovative high-tech pharβmaceutical enterprise that is market-oriented and realizes industrial development through R&D "innovation and technology transformation.

Clofarabine

It is a nucleotide analogue developed by Bioenvision and manufactu€red by Genzyme. On December 29, 2004, it was approved by FDA σfor the treatment of refractory or relapsed acute lymphoblastic leukemia (ALL) in ch₽ildren.

Upadacitinib(Scientific research)

Chenglian Pharmaceutical is an innovative high-tech pha≥rmaceutical enterprise that is market-oriented and realizes industrial development through R&D inαnovation and technology transformation.

Product Consulting

Our staff will contact you within 24 hours (working days). If you need other services, E-mail: 2880705932@qq.com
Submit

Copyright © 2022 Anhui Union Pharmaceuticals Technology Co., Ltd.